Name: LXRX Insider Trading Activity
Creator: Tracefour
License: https://www.usa.gov/government-works
Keywords: LXRX, insider trading, SEC Form 4, insider transactions

Question 1

How many SEC Form 4 insider filings does LXRX have?

Accepted Answer

LEXICON PHARMACEUTICALS, INC. (LXRX) has 21 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Jun 4, 2026.

Question 2

When was the most recent SEC Form 4 filing for LXRX?

Accepted Answer

The most recent Form 4 filing for LXRX on Tracefour is dated Jun 4, 2026.

Question 3

Who is the most active insider at LXRX?

Accepted Answer

The most active SEC Form 4 filer at LXRX in the rolling window is Director DEBBANE RAYMOND, with 7 filings.

Question 4

What is the net insider flow at LXRX over the last 6 months?

Accepted Answer

Over the trailing 180 days, insiders at LXRX have net bought $723K based on SEC Form 4 disclosures.

Question 5

What is the total insider buy and sell value at LXRX in the current window?

Accepted Answer

Inside the rolling window, insiders at LXRX bought $723K and sold $0 based on SEC Form 4 filings.

Question 6

Can I get alerts for LXRX insider trading?

Accepted Answer

Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at LEXICON PHARMACEUTICALS, INC. (LXRX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.

						Source
DEBBANE RAYMOND	Director	Purchase	2,000	$3K	Feb 27	SEC ↗
DEBBANE RAYMOND	Director	Purchase	100,000	$147K	Feb 25	SEC ↗
DEBBANE RAYMOND	Director	Purchase	50,000	$72K	Feb 23	SEC ↗
DEBBANE RAYMOND	Director	Purchase	100,000	$148K	Feb 23	SEC ↗
DEBBANE RAYMONDFirst filing	Director	Purchase	57,952	$76K	Feb 18	SEC ↗
DEBBANE RAYMONDFirst filing	Director	Purchase	76,857	$101K	Feb 18	SEC ↗
DEBBANE RAYMONDFirst filing	Director	Purchase	133,688	$176K	Feb 18	SEC ↗

LXRX

Related companies